PFO closure vs. medical therapy in cryptogenic stroke or transient ischemic attack: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 169, Issue 2, 2013, Pages 101-105

  Ntaios, G ^a   Papavasileiou, V ^a   Makaritsis, K ^a   Michel, P ^b  

^a UNIVERSITY OF THESSALY   (Greece)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

AMPLATZER PFO Occluder; Cryptogenic stroke; Paradoxical embolism; Patent foramen ovale; PFO closure; STARFlex device

Indexed keywords

BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; COMPARATIVE STUDY; DISEASE CONTROL; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; META ANALYSIS; NUMBERS NEEDED TO TREAT; PATENT FORAMEN OVALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SEPTAL OCCLUDER; SYSTEMATIC REVIEW; THERAPY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AMPLATZER PFO OCCLUDER; CRYPTOGENIC STROKE; PARADOXICAL EMBOLISM; PATENT FORAMEN OVALE; PFO CLOSURE; STARFLEX DEVICE;

FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SECONDARY PREVENTION; STROKE;

EID: 84887073013     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.08.058     Document Type: Review

References (27)

1. P. Michel, C. Odier, and M. Rutgers The Acute STroke Registry and Analysis of Lausanne (ASTRAL): design and baseline analysis of an ischemic stroke registry including acute multimodal imaging Stroke 41 2010 2491 2498
2. P.T. Hagen, D.G. Scholz, and W.D. Edwards Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts Mayo Clin Proc 59 1984 17 20
3. H.R. Jones Jr., L.R. Caplan, P.C. Come, N.W. Swinton Jr., and D.J. Breslin Cerebral emboli of paradoxical origin Ann Neurol 13 1983 314 319
4. S. De Castro, D. Cartoni, and M. Fiorelli Morphological and functional characteristics of patent foramen ovale and their embolic implications Stroke 31 2000 2407 2413
5. N.D. Bridges, W. Hellenbrand, L. Latson, J. Filiano, J.W. Newburger, and J.E. Lock Transcatheter closure of patent foramen ovale after presumed paradoxical embolism Circulation 86 1992 1902 1908
6. S. Agarwal, N.S. Bajaj, D.J. Kumbhani, E.M. Tuzcu, and S.R. Kapadia Meta-analysis of transcatheter closure versus medical therapy for patent foramen ovale in prevention of recurrent neurological events after presumed paradoxical embolism JACC Cardiovasc Interv 5 2012 777 789
7. M.A. Almekhlafi, S.B. Wilton, D.M. Rabi, W.A. Ghali, D.L. Lorenzetti, and M.D. Hill Recurrent cerebral ischemia in medically treated patent foramen ovale: a meta-analysis Neurology 73 2009 89 97
8. G.D. Kitsios, I.J. Dahabreh, A.M. Abu Dabrh, D.E. Thaler, and D.M. Kent Patent foramen ovale closure and medical treatments for secondary stroke prevention: a systematic review of observational and randomized evidence Stroke; a journal of cerebral circulation. 43 2012 422 431
9. A. Wahl, P. Juni, and M.L. Mono Long-term propensity score-matched comparison of percutaneous closure of patent foramen ovale with medical treatment after paradoxical embolism Circulation 125 2012 803 812
10. J.D. Carroll, J.L. Saver, and D.E. Thaler Closure of patent foramen ovale versus medical therapy after cryptogenic stroke N Eng J Med 368 2013 1092 1100
11. A.J. Furlan, M. Reisman, and J. Massaro Closure or medical therapy for cryptogenic stroke with patent foramen ovale N Eng J Med 366 2012 991 999
12. B. Meier, B. Kalesan, and H.P. Mattle Percutaneous closure of patent foramen ovale in cryptogenic embolism N Eng J Med 368 2013 1083 1091
13. S.R. Messe, and D.M. Kent Still no closure on the question of PFO closure N Eng J Med 368 2013 1152 1153
14. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, and P. Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Intern Med 151 2009 264 269 [W64]
15. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
16. M. Taaffe, E. Fischer, and A. Baranowski Comparison of three patent foramen ovale closure devices in a randomized trial (Amplatzer versus CardioSEAL-STARFlex versus Helex occluder) Am J Cardiol 101 2008 1353 1358
17. M. Hornung, S.C. Bertog, and J. Franke Long-term results of a randomized trial comparing three different devices for percutaneous closure of a patent foramen ovale Eur Heart J 2013 (Epub ahead of print)
18. P.M. Rothwell Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation Lancet 365 2005 176 186
19. P.M. Rothwell, Z. Mehta, S.C. Howard, S.A. Gutnikov, and C.P. Warlow Treating individuals 3: from subgroups to individuals: general principles and the example of carotid endarterectomy Lancet 365 2005 256 265
20. M.J. Sharafuddin, X. Gu, J.L. Titus, M. Urness, J.J. Cervera-Ceballos, and K. Amplatz Transvenous closure of secundum atrial septal defects: preliminary results with a new self-expanding nitinol prosthesis in a swine model Circulation 95 1997 2162 2168
21. G. Hausdorf, R. Kaulitz, T. Paul, M. Carminati, and J. Lock Transcatheter closure of atrial septal defect with a new flexible, self-centering device (the STARFlex Occluder) Am J Cardiol 84 1999 1113 1116 [A10]
22. U.S. Food, and Drug Administration Medical devices. Information for physicians and patients on the withdrawal of two humanitarian device exemptions (HDEs) for patent foramen ovale (PFO) occluders http://www.fda.gov/ MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/ PremarketSubmissions/HumanitarianDeviceExemption/ucm135747.htm October, 2006 [Retrieved August 05, 2013 from]
23. P. Kramer On horse sense and horse feathers: an argument against insistence on enrolling cryptogenic stroke patients with patent foramen ovale in randomized clinical trials Catheter Cardiovasc Interv 69 2007 1 3
24. K.A. Stackhouse, S.S. Goel, and A.M. Qureshi Off-label closure during CLOSURE study J Invasive Cardiol 24 2012 608 611
25. http://clinicaltrials.gov/ct2/show/NCT00738894 [Accessed: April 20, 2013]
26. http://clinicaltrials.gov/ct2/show/NCT00562289 [Accessed: April 20, 2013]
27. D.M. Kent, D.E. Thaler, and P.E.S.I. Ro The Risk of Paradoxical Embolism (RoPE) study: developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stroke Trials 12 2011 185